CLL Advocates Network Statement

CLL Advocates Network is closely monitoring the strategies being implemented in various countries to manage the COVID-19 virus. Much of the information about COVID-19 does not address the concerns of people with chronic lymphocytic leukaemia (CLL). With this statement, we wish to fill this gap and provide extra advice for CLL patients.

Most resources agree that the following individuals are at increased risk of severe or fatal COVID-19:

  • Older adults (60+ yrs.)
  • Individuals with coexisting chronic illnesses (e.g. chronic lung or heart diseases)
  • People contracting secondary infections

The following are at high risk of severe or fatal COVID-19:

  • Immune depressed individuals

CLL patients – whether treated or not, young or old – are immune depressed. Treatment can add to the immune deficiency. In view of the foregoing, CLL patients are therefore at high risk of getting COVID-19 and having more severe symptoms than the general population.

Armenian

New file V2, dd. April 10th

Danish

New file V2, dd. April 10th

Croatian

Updated April 10th

Czech

Updated April 10th

English

Updated April 10th

French

Updated April 10th

German

Updated April 10th

Italian

Updated April 10th

Kiswahili

New file V2, dd. April 10th

Serbian

Updated April 10th

Spanish

Updated April 10th

Further languages will follow.

If you can help translate the statement into your respective language, we would be grateful for support. Please contact us at info@clladvocates.net to ask for the editable files.

Make sure to also tag us in your communication on Facebook and Twitter with @CLLAdvocates

The previous statement dd. 26 March 2019 – available in 11 languages – can be accessed here.